Patient Education Sheet Library
Search Results
Tacrolimus
Tacrolimus is used for graft-versus-host disease (GVHD).
Treatment Given by Infusion Treatment Taken by MouthDownloads:
Download (English)Cyclophosphamide, Bortezomib, and Dexamethasone
The combination of cyclophosphamide, bortezomib, and dexamethasone (CyBorD or VCD) is used for multiple myeloma…
Treatment Given by Infusion Treatment Given by Injection Treatment Taken by MouthDownloads:
Pembrolizumab and Paclitaxel
The combination of pembrolizumab and paclitaxel is used for breast cancer and ovarian, fallopian tube,…
Treatment Given by Infusion Treatment Given by InjectionDownloads:
Zolbetuximab and FOLFOX
The combination of zolbetuximab and FOLFOX (leucovorin, fluorouracil (5-FU), and oxaliplatin) is used for stomach…
Treatment Given by InfusionDownloads:
Belantamab Mafodotin and Vd
The combination of belantamab mafodotin, bortezomib, and dexamethasone (BVd) is used for multiple myeloma (MM).
Treatment Given by Infusion Treatment Given by Injection Treatment Taken by MouthDownloads:
Atezolizumab and FOLFOX
The combination of atezolizumab and FOLFOX (leucovorin, fluorouracil (5-FU), and oxalilatin) is used for colon…
Treatment Given by Infusion Treatment Given by InjectionDownloads:
Zanubrutinib and Obinutuzumab
The combination of zanubrutinib and obinutuzumab is used for follicular lymphoma (FL).
Treatment Given by Infusion Treatment Taken by MouthDownloads:
Paclitaxel and Trastuzumab
The combination of paclitaxel and trastuzumab is used for breast cancer.
Treatment Given by Infusion Treatment Given by InjectionDownloads:
Ravulizumab
Ravulizumab is used for paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS).
Treatment Given by InfusionDownloads:
Bevacizumab, Carboplatin, and Paclitaxel
The combination of bevacizumab, carboplatin, and paclitaxel is used for non-small cell lung cancer (NSCLC)…
Treatment Given by InfusionDownloads:
Popular Searches
PES Review Committee
The Patient Education Sheet (PES) Committee is a multidisciplinary team of oncology professionals who guide the development and review of these important resources. This committee ensures that every PES is accurate, clear, and meaningful for patients and caregivers navigating cancer treatment.
Led by NCODA and supported through collaboration with three leading professional organizations—ACCC, HOPA, and ONS—the committee combines expertise from across the oncology care spectrum. Together, they uphold best practices, promote consistency in patient education, and remain committed to improving outcomes through accessible, patient-centered information.
